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The effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis
Looker, K. J., Elmes, J. A. R., Gottlieb, S. L., Schiffer, J. T., Vickerman, P., Turner, K. M. E. and Boily, M.-C.
FURTHER DETAILS ON THE METHODS
A. Search strategy and selection criteria For PubMed, we combined 2 searches: (1) article titles and abstracts were searched using the following keywords: (HIV*, human immunodeficiency virus, human immunedeficiency virus, human immune deficiency virus OR human immuno deficiency virus) AND (HSV*, herpes simplex, herpes virus type 2, herpes virus 2, herpesvirus 2, genital herpes OR herpes genitalis); (2) articles were searched using the following MeSH Terms: (herpes simplex OR simplexvirus) AND (human immunodeficiency virus, HIV infection, HIV antibodies, HIV seronegativity OR HIV seroprevalence). No terms were included for study design; longitudinal study design was identified at the screening stages.
For Embase, the search strategy was as follows: HIV*.ti,ab, human immun#deficiency virus.ti,ab, human immun# deficiency virus.ti,ab (all keywords), exp [loded] human immunodeficiency virus, exp human immunodeficiency virus infection, exp human immunodeficiency virus antibody, human immunodeficiency virus prevalence OR exp HIV test (all mapped terms), AND: HSV*.ti.ab, herpes simplex.ti,ab, herpes virus type 2,ti.ab, herpes virus 2.ti,ab, herpesvirus 2.ti,ab, genital herpes.ti,ab, herpes genitalis.ti,ab (all keywords), simplexvirus, exp[loded] herpes simplex virus 2 OR exp herpes simplex (all mapped terms), AND: inciden*.ti,ab, longitudinal*.ti,ab, prospective*.ti,ab, cohort*.ti,ab, follow up.ti,ab, follow*up.ti,ab, follow* up.ti,ab, case-control.ti,ab, trial.ti,ab, time series*.ti,ab, intent* to treat.ti,ab, clinical trial.ti,ab, seroinciden*.ti,ab, seroconvert*.ti,ab, control group*,ti.ab, time to event*.ti,ab, RCT*.ti,ab, hazard*.ti,ab, retrospective*,ti,ab (all keywords), exp [loded] incidence, exp disease course, exp longitudinal study, exp time, exp prospective study, exp cohort analysis, exp survival, exp follow up, exp case control study, exp retrospective study, exp control group, exp attributable risk, exp risk factor, exp infection risk, exp infection rate, exp virus transmission, exp clinical trial (topic) OR exp randomized controlled trial (topic) (all mapped terms).
Searches were not restricted by language or bibliographic database filters. We excluded crosssectional studies, studies with no primary data or report of the association between HSV-2 and HIV, studies not diagnosing HSV-2 infection with a type-specific antibody assay, studies relying on self-reported HIV status, and studies limited to HSV-2-infected and/or HIV-infected individuals only (i.e., no uninfected participants were included). We did not exclude studies on the basis of study quality, which was assessed in detail. Reference lists of retrieved full-text articles and other reviews were also checked to identify additional potential publications (2) .
B. Data extraction
Crude cRR and adjusted aRR (and 95%CIs) based on hazard or incidence rate ratios (HR and IRR respectively), or odds ratios (OR), were extracted, or derived from available data. We used the following formulae for calculating cRR (or their 95%CIs) from given numbers in the papers where estimates were not directly reported: logIRR = ln ((d1/T1)/(d0/T0)) selogIRR = sqrt(1/d1 + 1/d0) logOR = ln ((d1/(N1-d1))/(d0/(N0-d0))) selogOR = sqrt(1/d1 + 1/d0 + 1/(N1-d1) + 1/(N0-d0))
where d0 are d1 are the number of unexposed and exposed cases, respectively, N0 and N1 are the number in the unexposed and exposed population, respectively, and T0 and T1 are the total personyears at risk for the unexposed and exposed population, respectively.
For the subsequent meta-analysis, standard errors were calculated from:
where θ is either HRR, IRR or OR, UCB is the upper confidence bound and LCB is the lower confidence bound.
Studies reporting only the significance/non-significance of an association without an estimate, or which could have estimated an association but did not report the results were included. Where multiple publications reported on the same study population, we preferably extracted estimates based on HR from cox regression model or IRR and then on the largest sample size.
We extracted available RR stratified by age, sex, study year, and study arm (for controlled trials). In addition, we extracted information on several participant characteristics (e.g., age, sex, population, and WHO region, the latter subsequently used to define world region) and study characteristics (e.g., study years, study design, sample size, length and rate of follow-up, frequency of sampling, HSV-2 exposure, unexposed comparison group definition, and key potential confounders adjusted for: male circumcision status, condom use, female hormonal contraception use, sexual behaviour (any related variable except condom use), genital ulcer disease (GUD), number of sexual partners and age). We noted if estimates were inappropriately adjusted for GUD, because GUD, which is often caused by HSV-2, is likely to be on the causal pathway to HIV since ulcers can act as a portal of entry for HIV (3, 4) . Follow-up rate was defined as the fraction of individuals eligible for inclusion in the study with at least one follow-up visit for HIV. Thus, follow-up rate was a function of (a) the proportion of eligible individuals recruited; (b) the proportion of recruited individuals with subsequent follow-up; and (c) the proportion of followed-up individuals with HSV-2 and HIV testing. The number of individuals at each stage of the study was not always available; therefore we computed the follow-up rate using as much information as was available, meaning follow-up rate was in some instances overestimated. The follow-up rate for the overarching cohort study or controlled trial was used for nested case-control studies. For those studies included in previous reviews(1, 5) we extracted estimates and information from the original publications rather than from the reviews. The exception was for information and/or estimates obtained through author contact by Freeman et al. (1) .
RR estimates of HIV following exposure to incident HSV-2 infection were classified in five timing categories reflecting uncertainty in the time sequence between HSV-2 and HIV seroconversion as follows: first, we noted whether the estimate included (a) HSV-2 seroconversion prior to HIV seroconversion (Yes/No/Unknown); (b) HSV-2 seroconversion in the same study interval as HIV seroconversion (Yes/No/Unknown); and (c) HSV-2 seroconversion after HIV seroconversion (Yes/No/Unknown). Second, using these responses we defined: 1=HSV-2 seroconversion observed in previous time interval and thus HSV-2 infection happened before HIV (definitely before); 2=HSV-2 seroconversion observed in same time interval as HIV and thus HSV-2 infection may have happened before or after HIV (indeterminably close); 3=HSV-2 seroconversion observed in previous or in same time interval as HIV (before & indeterminably close); 4a=some HSV-2 seroconversion may have occurred after HIV (maybe after & indeterminably close/before); 4b=some HSV-2 seroconversion observed after HIV (after & indeterminably close/before).
C. Newcastle-Ottawa Quality Assessment Scale assessment
Our criteria for awarding a star in each category of the Newcastle-Ottawa Quality Assessment Scale was as follows:
Case-control studies (including nested case-control studies) 
D. Principal meta-analysis
All estimates within each sub-category for pooling were independent (i.e., for non-overlapping study populations). In some studies, more than one estimate was shown and pooled per sub-category in the main meta-analysis, corresponding to independent estimates from more than one country or city.
E. Assessment of heterogeneity
We investigated the impact of heterogeneity across independent RR using the I 2 statistic(6), which is the percentage variation between effect sizes that is attributable to heterogeneity rather than sampling error. The following guidance for interpretation of the I 2 statistic has been suggested: low: I 2 =25-30%; moderate: I 2 =50-75%; and high: I 2 ≥75%(7).
Only independent aRR were included in the meta-regression; we preferentially selected aRR of the association between HIV acquisition following exposure to incident HSV-2 infection over exposure to prevalent HSV-2 infection, where both were available from a study.
The meta-regression did not show the absolute effect of a factor in the association between HSV-2 infection and HIV acquisition. Therefore, sub-group analyses of aRR were conducted separately for the incident and prevalent HSV-2 exposures to produce pooled estimates of the association between HSV-2 infection and HIV acquisition. This was done for factors deemed epidemiologically important a priori (i.e., female sex workers (FSWs), men who have sex with men (MSM), risk group, age, sex, definition of unexposed comparison group, HIV testing frequency and timing sequence for incident HSV-2 infection) and any additional statistically significant factors identified in the univariable metaregression. The definition of unexposed comparison group and HIV testing frequency were explored because both may introduce misclassification biases and bias RR estimates toward the null. Timing sequence was explored as this may bias RR estimates following exposure to incident HSV-2 infection in either direction. Estimates were added in for the sub-pooling if available by sub-categories, but still ensuring only independent study estimates were included within a sub-category.
F. Funnel plots
The funnel plots show the log (In) study estimate and its corresponding standard error (SE), constructed using the "metafunnel" command in Stata (8) . The centre line is the fixed-effects pooled estimate with pseudo 95%CI (i.e., summary effect ± 1·96 * SE). This gives the estimated area where 95% of study estimates are expected to fall in in the absence of statistical heterogeneity. The plots also show Egger's test of asymmetry (9). This is a linear regression line through the estimates which aids in the assessment of publication bias.
FURTHER RESULTS

G. Additional forest plots and meta-analyses
Supplementary Figure S1 . Pooled crude cRR estimates of the association between HIV incidence and exposure to HSV-2 infection
Footnote: Estimates for both prevalent HSV-2 infection on HIV acquisition, and incident HSV-2 infection on HIV acquisition (timing=1; i.e., HSV-2 seroconversion observed in previous time interval and thus definitely before HIV), are shown on this plot. Estimates are presented for females and males combined where these could not be obtained separately by sex. Multiple estimates for the same study corresponding to different study countries or areas are presented where these could not be combined or where it was not appropriate to do so (i.e., countries span two sub-regions) (*); however all estimates are independent (i.e., for non-overlapping study populations) within each HSV-2 exposure category. Estimates are ordered by WHO region, UN Population Division African sub-region and then mid-point of study year.
H. Funnel plots to assess publication bias
Supplementary Figure Figures 2 and 3 , Appendix Figure S1 and Table 2 );
6 Men with higher-risk sexual behaviour (likely to be MSM), STI clinic attendees, male trucking company employees, clients of FSWs and Thai military conscripts (grouped with MSM in Figures 2 and 3 , Appendix Figure S1 and Table 2) ; 7 Estimates by sex could not be obtained; 8 May be estimated from range; 9 All case-control studies subsequently analysed together; FSWs -Female sex workers; MSM -Men who have sex with men; GUD -Genital ulcer disease; HR -Hazard ratio; IRR -Incidence rate ratio; OR -Odds ratio. Figures 2 and 3 , Appendix Figure S1 and Table 2 ); 7 Men with higher-risk sexual behaviour (e.g. clients of FSWs), STI clinic attendees and Thai military conscripts (grouped with MSM in Figures  2 and 3 , Appendix Figure S1 and Table 2 ); 8 Estimates by sex could not be obtained; 9 May be estimated from range; 10 All case-control studies subsequently analysed together; FSWs -Female sex workers; MSM -Men who have sex with men; GUD -Genital ulcer disease; HR -Hazard ratio; IRR -Incidence rate ratio; OR -Odds ratio.
Supplementary Table S3 . Description of study characteristics relevant to the assessment of study quality for the association between HIV incidence and exposure to HSV-2 infection, and results of the Newcastle-Ottawa scale assessment Adjusted for (any) sexual behaviour? Adjusted for genital ulcer disease? Estimate shown in Figure 2 or Figure S1 ? Selection 1) 
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